GM, I’m sharing this link to help a friend in Venezuela who is raising funds to help his mother Rosa who has been battling breast cancer for 10 years. After many years of successful treatments she was recently told they are no longer working. Doctors recommend she undergo the Oncodeep Plus study, a test that can help specialists accurately identify which treatments might be most effective. The testing isn’t available in Venezuela, which makes an already expensive cost even more expensive. Their family has helped as much as they can for many years but now they need help to get this testing done. Please consider making a donation, every bit helps and will mean so much to their family. I’ll be making a donation to Rosa in honor of my Rose🌹 If you need a translation HMU gofundme.com/f/ayudame-a-fin…

Join us on the 5th Feb to learn about OncoDEEP, the new testing technology for solid tumours. Registration is open to everyone but will be especially useful if you work in the solid tumour testing pathway. Sign- up via the QR below or the link here: bit.ly/4jeUaaY

👉Изследването OncoDEEP® е част от цялостната платформа OncoKDMTM, която позволява на потребителите да проучат параметрите на контрол и качество при всяка анализирана проба. Приложението на OncoKDMTM осигурява достъп до база данни, включваща над 4 500 000 генетични варианта, 1 150 лекарствени продукта и 7 000 клинични проучвания. Удобните за потребителите софтуерни инструменти улесняват генерирането на клинично значими резултати за пациента. Лабораторията по молекулярна патология към Gustave Roussy коментира радостта на екипа от прилагането на изследването OncoDEEP® и използването на платформата OncoKDMTM като най - добро решение за молекулярна характеристика за анализ на туморни кохорти. ✅Не забравяйте, че можете да се възползвате от -10% от всички изследвания на OncoDNA в портфолиото на NM Genomix! Вижте повече за изследването OncoDEEP®: nmgenomix.com/oncodeep/

I am so sorry Kate, i was on Epirubicin 8 years ago for 6 sessions with Cyclophosphamide, if that’s how you spell it. It was tough but tolerable. Have you had your latest tumour biopsied and genetically tested? I’m sure that you have but mine was tested by Oncodeep. Huge hug xx

Campaña de Fanny Gomez Sanchez : Examen post Operatorio Exceresis de Loe (OncoDeep) gofund.me/b1b8383f

El hijo de un amigo de la infancia requiere hacerse un OncoDeep, examen sumamente costoso. No cuentan con los recursos. Cualquier institución o Alma caritativa que desee ayudar se puede comunicar al 04121749891. Gracias 🙏

We are delighted to communicate about our collaboration with @LillyPad - Italia to broaden access to biomarker testing for #thyroid cancer patients 🧬. Discover all details in our press release: ow.ly/5o0a50LMYY0 #oncodna #oncodeep #cancer #precisiononcology #NGS

OncoDNA is pleased to announce a transformational partnership with the Berkshire and Surrey Pathology Services to facilitate Private NGS testing across UK 🙌. Discover all details in our press release: ow.ly/7xXU50LcM0n #oncodna #oncodeep #precisiononcology

We have launched our new #OncoDEEP Kit during the #ESMO in Paris. It enables laboratories with #NGS capabilities to support oncologists in finding the most effective and personalized treatments for their cancer patients🔬. Discover all details: ow.ly/GErN50KI8ib

OncoDNA presenta en el Congreso de la Sociedad Europea de Oncología Médica OncoDEEP, el kit genómico para estudiar tumores sólidos saludediciones.com/2022/09/1… @DonJuanMiguel4 @carloshern79 @SastreFrancesc @josecodony @macalafat

OncoDEEP kit launch on a boat cruise on the Seine, ⁦@OncoDNA⁩ ⁦@DetiffeOncoDNA⁩

ALK. ROS1. FGFR. NTRK. BRAF. They are all #genefusion biomarkers that can predict a patient’s sensitivity to targeted and hormone therapy. Watch the video to understand how to detect them in patients. youtube.com/watch?v=wFI4NqTd… #oncology #OncoDEEP #precisionmedicine

Why test patients with metastatic castration-resistant #prostatecancer for #ARV7? This #biomarker is associated with a poor prognostic indicator for the efficacy of #hormonetherapies such as abiraterone or enzalutamide. #OncoDEEP can help detect it => ow.ly/WJXg50HYu00

Why is it important to test #urothelialcancer #cholangiocarcinoma patients for #FGFRs? Using #DNAseq #RNAseq to detect FGFRs can help predict patient response to #targetedtherapies such as erdafitinib and pemigatinib. #OncoDEEP combines all analyses => ow.ly/bnaB50HYtMX

This month, #bladder cancer is in the spotlight: optimize #treatmentstrategy for your patients with advanced or metastatic #urothelialcarcinoma with #OncoDEEP. Identify all clinically relevant #biomarkers in one simple test! #precisionmedicine #oncology #cancer #solidbiopsy

Why test #NSCLC patients for #METex14 unusual splicing, and #ROS #ALK #RET translocations? All are associated with FDA-approved #targetedtherapies. Our #OncoDEEP uses #DNAseq #RNAseq to detect such complex biomarkers & flag patients that are eligible. ow.ly/u4o750HYt9p

A clinical study highlights the power of combining #NGS and #IHCs to optimize treatment strategies for cancer patients 🧬. Curious to know more about this study? Access the publication here: ow.ly/e24x50IwRxF #OncoDEEP #biomarkertest #precisionmedicine #oncology

OncoDNA, Synlab Partner to Offer Cancer Biomarker Testing Services in Germany. Synlab will perform OncoDNA's OncoDeep cancer sequencing test in its laboratories in Germany to evaluate solid tumors and provide treatment decision support. ow.ly/Ekf5103w0hu

Why test cancer patients for #NTRK gene fusions? With #precisionmedicine, there now exist pan-cancer treatments that target #NTRK. At OncoDNA, our #OncoDEEP test utilizes #DNAseq #RNAseq to detect patients that may benefit from these TRK inhibitors. ow.ly/M0TT50HYsV4

#RNA biomarkers, #OncoDEEP upgrade! As of today, all our comprehensive biomarker tests will include 20 additional #biomarkers visible at RNA level in solid tumors. One example of RNA biomarkers is #genefusions. Discover more about it in the video below: ow.ly/Lb9A50HWFf9